General Information of Drug (ID: DMZ1FRS)

Drug Name
Propidium Drug Info
Synonyms
PROPIDIUM; 36015-30-2; UNII-74NX23J96Y; CHEBI:51246; 74NX23J96Y; 3,8-DIAMINO-5[3-(DIETHYLMETHYLAMMONIO)PROPYL]-6-PHENYLPHENANTHRIDINIUM; Phenanthridinium, 3,8-diamino-5-(3-(diethylmethylammonio)propyl)-6-phenyl-; 3,8-diamino-5-{3-[diethyl(methyl)ammonio]propyl}-6-phenylphenanthridinium; CHEMBL345124; PRM; Propidium Iodide, 2; AC1Q1IXP; Prestwick1_000792; Prestwick0_000792; Prestwick2_000792; Prestwick3_000792; AC1L1J9Q; CBiol_001968; SCHEMBL55279; BSPBio_000924; KBioSS_000378; KBioGR_000378; BSPBio_001038; SPBio_002863
Cross-matching ID
PubChem CID
4939
ChEBI ID
CHEMBL332935
CAS Number
CAS 36015-30-2
TTD Drug ID
D08UET

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Galactose metabolism 1.97 7.10e-3 26/31 (83.87%) PFKP;HK2;G6PC3;...
IL-17 signaling pathway -1.68 3.63e-2 84/94 (89.36%) TRAF3;JUN;MAPK1;...
T cell receptor signaling pathway -1.68 3.62e-2 93/104 (89.42%) IL5;ZAP70;PPP3R1;...
NOD-like receptor signaling pathway -1.72 2.06e-2 145/181 (80.11%) IRF3;OAS2;TRAF6;...
Viral protein interaction with cytokine and cytokine re... -1.74 1.91e-2 84/100 (84%) TNFSF14;CXCL13;IL10;...
Primary immunodeficiency -1.77 1.49e-2 33/38 (86.84%) ZAP70;CD40;IL2RG;...
Leishmaniasis -1.77 1.65e-2 67/77 (87.01%) TRAF6;NFKBIB;CR1;...
Type I diabetes mellitus -1.78 1.86e-2 38/43 (88.37%) HLA-F;ICA1;CD86;...
African trypanosomiasis -1.78 2.12e-2 32/37 (86.49%) MYD88;IL10;HBB;...
Malaria -1.81 1.86e-2 44/50 (88%) CD81;CD40;GYPC;...
Allograft rejection -2.03 0.00e+0 32/38 (84.21%) IL2;CD28;HLA-F;...
Graft-versus-host disease -2.09 0.00e+0 32/42 (76.19%) HLA-F;CD86;FASLG;...
NF-kappa B signaling pathway -2.12 0.00e+0 90/104 (86.54%) LCK;TRAF3;ERC1;...
TNF signaling pathway -2.22 0.00e+0 103/112 (91.96%) MAP2K3;MMP14;TRAF3;...
Rheumatoid arthritis -2.28 0.00e+0 78/93 (83.87%) CSF2;FOS;TLR4;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H